Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Oxalate induces breast cancer
Oxalate induces proliferation of breast cells and stimulates the expression of a pro-tumorigenic gene
c-fos
.
»
10/22/15
Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3′-oxime (7BIO)
Treated cells showed DNA fragmentation.
»
10/12/15
RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
LNCaP-PSCA showed significantly enhanced primary tumor growth and metastasis.
»
12/09/14
MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
agomiR-145 downregulated TRIM2 to derepress Bim (a pro-apoptotic Bcl-2 family member).
»
07/14/15
Inhibition of casein kinase 1 alpha prevents acquired drug resistance to erlotinib in EGFR-mutant non-small cell lung cancer.
Combination of EGFR TKIs and CK1 alpha inhibition to prevent acquired drug resistance and prolong disease-free survival.
»
10/23/15
Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
GMP scores of cancerous tissue combined with UGT1A1 genotyping of blood samples may serve as highly potent markers for predicting the efficacy of NAC.
»
01/29/15
TRIM28 as an independent prognostic marker plays critical roles in glioma progression.
Over-expression of TRIM28 is associated with poor outcome in glioma patients.
»
03/16/15
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.
The primary end point was adenomas diagnosed in the interval from randomization through the anticipated surveillance colonoscopy.
»
10/15/15
Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer.
D1R overexpression is associated with advanced breast cancer.
»
03/17/15
ATDC/TRIM29 drives invasive bladder cancer formation through microRNA-mediated and epigenetic mechanisms.
ATDC as a candidate biomarker and therapeutic target.
»
09/03/15
< Prev
Next >